Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compound classification using image-based cellular phenotypes.

Cynthia L Adams1, Vadim Kutsyy, Daniel A Coleman

  • 1Cytokinetics Inc., South San Francisco, CA, USA.

Methods in Enzymology
|November 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The inspiration of methyltransferase in RNA methylation modification for targeted therapy of malignant tumors.

Frontiers in immunology·2025
Same author

Mechanisms and therapeutic potential of the hedgehog signaling pathway in cancer.

Cell death discovery·2025
Same author

Blinding properties of methods for supplying drug kits to investigational sites.

Contemporary clinical trials communications·2018
Same author

Rapid intraoperative histology of unprocessed surgical specimens via fibre-laser-based stimulated Raman scattering microscopy.

Nature biomedical engineering·2017
Same author

Discovery of omecamtiv mecarbil the first, selective, small molecule activator of cardiac Myosin.

ACS medicinal chemistry letters·2014
Same author

The other randomization - methods for labeling drug kits.

Contemporary clinical trials·2014
Same journal

Clinical Europium fluorescent based lectin assays for mucin O-glycomics.

Methods in enzymology·2026
Same journal

A dual-color FRET assay for detection and quantitative analysis of O-glycopeptidases.

Methods in enzymology·2026
Same journal

Evolutionary genetic approaches to analyze mucins.

Methods in enzymology·2026
Same journal

Ex vivo imaging and enzymatic analysis of intestinal mucus.

Methods in enzymology·2026
Same journal

Glyco-TRAPP: A real-time glycocalyx permeability assay for assessing transmembrane mucin barrier function in live and fixed tissues.

Methods in enzymology·2026
Same journal

Quantitative imaging approaches to capture structural and functional dynamics of colonic mucus in health and disease in situ.

Methods in enzymology·2026
See all related articles

We developed an automated image-based system to classify compounds by their cellular effects, enabling accurate mechanism of action determination and identification of unintended activities in drug discovery.

Area of Science:

  • Cellular biology
  • Pharmacology
  • High-content screening

Background:

  • Similar compound targets and inhibition modes induce comparable cellular phenotypes.
  • This principle allows for the classification of compounds based on observed cellular changes.

Purpose of the Study:

  • To quantitatively classify compounds with diverse mechanisms of action using cellular phenotypes.
  • To identify compounds exhibiting unintended cellular activities within a chemical series.
  • To develop an automated image-based system for high-throughput cellular phenotype analysis.

Main Methods:

  • Development of Cytometrix technologies, a highly automated image-based system.
  • Quantification, clustering, and classification of cellular phenotype changes.

Related Experiment Videos

  • Application of the system to known compounds and related chemical series.

    • Main Results:

    • Accurate classification of 45 out of 51 known compounds into 12 distinct mechanisms of action.
    • Identification of microtubule-binding activity in a cytochalasin actin poison.
    • Demonstration of the system's capability in drug discovery screening.

    Conclusions:

    • Cytometrix technology enables precise classification of compound mechanisms of action.
    • The system effectively detects unintended activities and toxicities in drug candidates.
    • This automated approach significantly advances high-throughput screening and secondary assays in drug discovery.